|
Long-term outcomes in patients with localized Ewing sarcoma treated with interval-compressed chemotherapy: A long-term follow-up report from Children’s Oncology Group study AEWS0031. |
|
|
|
Consulting or Advisory Role - Y-mAbs Therapeutics |
Research Funding - Celgene; Roche/Genentech (Inst) |
(OPTIONAL) Uncompensated Relationships - Lilly; United Therapeutics |
|
|
Consulting or Advisory Role - Merck Sharp & Dohme |
Travel, Accommodations, Expenses - Merck Sharp & Dohme |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Agios; Daiichi Sankyo; Illuminoss; Stryker |
Consulting or Advisory Role - Agios; Daiichi Sankyo; Illuminoss; Stryker |
Speakers' Bureau - Stryker |
Travel, Accommodations, Expenses - agios; Daiichi Sankyo; illuminoss; Stryker |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Bayer |
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst) |
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals |
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Eisai; Pfizer; SpringWorks Therapeutics |
|
|
Consulting or Advisory Role - BioAtla |
Travel, Accommodations, Expenses - SpringWorks Therapeutics |
|
|
Research Funding - Eisai (Inst) |
|
|
Honoraria - Foundation Medicine; Takeda |
Consulting or Advisory Role - Bayer; Ipsen; Ipsen |
Travel, Accommodations, Expenses - Bayer |
|
|
No Relationships to Disclose |